Biogen board replacement for Alex Denner, Susan Langer, is said to be the investor’s romantic partner
On Monday night, Biogen announced a change to its board to add Susan Langer as a director, as longtime member Alex Denner and two others leave the board.
While Langer has a long résumé in biotech, including a corporate role at Biogen, a stint as a VC, and as a company founder, she is also Denner’s longstanding romantic partner, Endpoints News has been told by people familiar with the situation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.